Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib (Q28259638)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib
scientific article

    Statements

    Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib (English)
    0 references
    0 references
    0 references
    Hayes M Dansky
    0 references
    Michael Davidson
    0 references
    Antonio M Gotto
    0 references
    A Lawrence Gould
    0 references
    Michael Stepanavage
    0 references
    Sherry Xueyu Liu
    0 references
    Sukrut Shah
    0 references
    Joseph Rubino
    0 references
    Patrice Gibbons
    0 references
    Anne Hermanowski-Vosatka
    0 references
    Bruce Binkowitz
    0 references
    Yale Mitchel
    0 references
    Philip Barter
    0 references
    October 2009
    0 references
    158
    0 references
    513-519.e3
    0 references
    4
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit